CT Imaging for Guiding PA-TACE for HCC

CT Imaging for Guiding Postoperative Adjuvant Transarterial Chemoembolization for Hepatocellular Carcinoma

Postoperative adjuvant transarterial chemoembolization (PA-TACE) may improve survival outcomes in a subset of patients with resected hepatocellular carcinoma (HCC), reliable biomarkers for the criterion for the selection of candidates are lacking. The present study aimed to evaluate whether CT imaging can provide more value for predicting benefit from PA-TACE.

Inclusion Criteria:

• CT scans acquired no more than one month before surgery
• Confirmation of HCC diagnosis by pathological examination
• Curative surgical resection

Exclusion Criteria:

• Prior antitumor treatment
• Macrovascular thrombosis or metastasis
• Perioperative mortality
• Unqualified image artifacts
• Tumor rupture
• MVI status not reported